Welcome to the e-CCO Library!

P317: Patient satisfaction in a joint fistula clinic at a tertiary Inflammatory Bowel Disease centre in the United Kingdom
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mukhtar, M.S.H.(1)*;Lim, W.J.(2);Tozer, P.(3);Hart , A.(2);
Created: Friday, 14 July 2023, 11:05 AM
P317: Postoperative complications, outcome, quality of life and self-image after ileal pouch-anal anastomosis in patients operated due to acute, severe or chronic, therapy refractory ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Balint A.*1, Czinderi V.1, Szucs M.2, Rutka M.1, Farkas K.1, Szepes Z.1, Nagy F.1, Fábián A.1, Bor R.1, Milassin A.1, Lázár G.3, Molnár T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P317: Societal cost-of-illness of Inflammatory Bowel Disease has rapidly increased over the years and differs between continents: A systematic review
Year: 2021
Source: ECCO'21 Virtual
Authors: Van Linschoten, R.(1);Visser, E.(2);Niehot, C.(3);van der Woude, J.(4);Hazelzet, J.(5);van Noord, D.(1);West, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P317: Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Straatmijer , T.(1);Biemans , V.B.C.(1);Moes , D.J.A.R.(2);Hoentjen , F.(7);ter Heine , R.(4);Maljaars , P.W.J.(5);Theeuwen , R.(5);Pierik , M.(6);Duijvestein , M.(3);van der Meulen , A.E.(5);
Created: Friday, 11 February 2022, 3:52 PM
P318 Artificial intelligence of the neural network-assistant for differential diagnosis of IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Skalinskaya1, I. Bakulin1, E. Skazyvaeva1, I. Rasmagina1, G. Mashevskii2, N. Shelyakina2, K. Ivanova1, D. Berest1

Created: Thursday, 30 January 2020, 10:12 AM
P318: Accuracy of magnetic resonance enterography for extraluminal complications of Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pecoraro G.M.*1, Orlando A.2, TesÈ L.3, Solina G.4, Di Mitri R.5, Mocciaro F.5, Renna S.2, Cottone M.2

Created: Wednesday, 20 February 2019, 10:36 AM
P318: Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Rodriguez Alonso1*, K. Serra1, E. Santacana2, N. Padullés2, C. Arajol1, P. Gilabert1, J. Orobitg1, F. Rodríguez-Moranta1, H. Colom3, A. Padullés2, J. Bas4, J. Guardiola1

Created: Thursday, 21 February 2019, 9:14 AM
P318: Does anti-tumour necrosis factor therapy decrease the risk of initial intestinal resection after the diagnosis of Crohn’s disease? A retrospective single-centre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Nagata*1, M. Esaki1, A. Hirano1, J. Umeno1, Y. Maehata1, T. Torisu1, T. Moriyama1, T. Matsumoto2, T. Kitazono1

Created: Friday, 22 February 2019, 9:49 AM
P318: Intra-dermal with topical imiquimod pre-treatment versus intra-muscular hepatitis B vaccination in inflammatory bowel disease patients: a double-blind randomized controlled trial
Year: 2021
Source: ECCO'21 Virtual
Authors: Ko, K.L.(1);Lam, Y.F.(1);Cheung, K.S.(1);Hung, F.N.(1);Leung, W.K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P318: Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mortensen, J.(1)*;Focht, G.(2);Pehrsson, M.(1);Griffiths, A.M.(3);Alexdóttir, M.S.(1);Quteineh, A.(2);Church, P.C.(3);Baldassano, R.N.(4);Silverstein, J.(5);Karsdal, M.A.(1);Turner, D.(2);
Created: Friday, 14 July 2023, 11:05 AM
P318: Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
Year: 2022
Source: ECCO'22
Authors: Drügg Hahn, G.(1);Golovics, P.(1);Wetwittayakhlang, P.(1);Santa Maria, D.(2);Britto, U.(2);Wild, G.(1);Afif, W.(1);Bessissow, T.(1);Bitton, A.(1);LakatosPhD, P.L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P318: Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Gadhok*1, R. Rao1, S. Honap2, M. Samaan3, L. Harpham-Lockyer3, H. Kwok3, L. Whitley3, A. Ibarra1, N. Burgess1, E. Seward3, G. Parkes1, S. Mehta3, R. Vega3, S. McCartney3, S. Bloom3, P. Irving2, J. O. Lindsay1, K. Kok1, F. Rahman3

Created: Friday, 22 February 2019, 9:41 AM
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I.V. Gubonina, V. Grinevich, M. Poluektov, T. Kolodin, S. Lapteva, A. Gamzaeva, N. Gubonina, MMA-IBD Group

Created: Thursday, 30 January 2020, 10:12 AM
P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vázquez-Morόn J.M.*1, Benítez-Rodríguez B.2, Pallarés-Manrique H.1, Machancoses F.H.3, Robles Rodríguez J.L.4, Ramos-Lora M.1, Ruíz-Frutos C.5

Created: Wednesday, 20 February 2019, 10:36 AM
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kobayashi, T.(1)*;Dignass, A.(2);Roblin, X.(3);Fujitani, Y.(4);Oortwijn, A.(5);Jamoul, C.(6);Hibi, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

U. Kopylov*1, K. Papamichael2, 3, K. Katsanos4, M. Waterman5, A. Bar-Gil Shitrit6, T. Boysen7, F. Portela8, A. Peixoto9, A. Szilagyi10, M. Silva9, G. Maconi11, O. Har-Noy1, P. Bossuyt12, G. Mantzaris2, M. Barreiro de Acosta13, M. Chaparro14, D. Christodoulou4, R. Eliakim1, J.-F. Rahier15, F. Magro9, S. Ben-Horin16, X. Roblin17

Created: Friday, 22 February 2019, 9:49 AM
P319: Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: García García, M.J.(1);Rivero, M.(1);Miranda-Bautista, J.(2);Bastón-Rey, I.(3);Mesonero, F.(4);Leo-Carnerero, E.(5);Casas-Deza, D.(6);Cagigas Fernández, C.(7);Martin-Cardona, A.(8);El Hajra, I.(9);Hernández-Aretxabaleta, N.(10);Pérez-Martínez, I.(11);Fuentes-Valenzuela, E.(12);Jiménez, N.(13);Rubín de Célix, C.(14);Gutiérrez, A.(15);Suárez Ferrer, C.(16);Huguet, J.M.(17);Fernández-Clotet, A.(18);González-Vivó, M.(19);Del Val, B.(20);Castro-Poceiro, J.(21);Melcarne, L.(22);Dueñas, C.(23);Izquierdo, M.(24);Monfort, D.(25);Bouhmidi, A.(26);Ramírez De la Piscina, P.(27);Romero, E.(28);Molina, G.(29);Zorrilla , J.(30);Calvino-Suárez, C.(3);Sánchez, E.(4);Nuñez, A.(5);Sierra, O.(6);Castro, B.(1);Zabana, Y.(8);González-Partida, I.(9);Chaparro, M.(14);Gisbert, J.P.(14);
Created: Wednesday, 2 June 2021, 4:12 PM
P319: Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
Year: 2022
Source: ECCO'22
Authors: Aleman Gonzalez, H.(1);Ramachandran, S.(1);Whitehead, E.(1);Pattinson, A.(1);Stamp, K.(1);Turnbull, J.(1);Myers, S.(1);Talbot, A.(1);Sebastian, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P319: Long-term outcomes after anti-TNF therapy withdrawal in patients with radiologically healed perianal Crohn’s fistulas
Year: 2018
Source: ECCO '18 Vienna
Authors:

W.Y. Mak1*, S. Adegbola2, K. Sahnan2, P. Tozer2, P. Lung2, A. Hart2, S.C. Ng3

Created: Thursday, 21 February 2019, 9:14 AM
P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. H. Oh*1, A-R. Yoon2, S. H. Park3, J. Kim1, N. Ham1, E. M. Song1, S. W. Hwang1,2, S. H. Park1,2, D-H. Yang1, J-S. Byeon1, S-J. Myung1, S-K. Yang1,2, B. D. Ye1,2

Created: Friday, 22 February 2019, 9:41 AM